Multibagger pharma penny stock at Rs 12 per share : Board Approves 1:10 Stock Split, 1:10 Bonus Issue, and Authorized Share Capital Increase
DSIJ Intelligence-2Categories: Mindshare, Multibaggers, Penny Stocks, Trending
The stock is up by 97 per cent from its 52-week low of Rs 6.40 per share and has given multibagger returns of 630 per cent in 5 years.
Welcure Drugs & Pharmaceuticals Ltd announced a set of corporate actions on Friday, August 22, 2025, following its Board of Directors meeting. The decisions include a stock split, a bonus issue, and an increase in authorised share capital.
DSIJ’s 'Multibagger Pick’ service recommends well researched multibagger stocks with High Returns potential. If this interests you, download the service details here.
Stock Split in 1:10 Ratio
The Board approved the sub-division of equity shares in the ratio of 1:10. Each share of Rs 10 face value will be split into ten equity shares of Rs 1 each. This step is expected to improve liquidity and make shares more accessible for retail investors in the Small-Cap segment.
Before the split, the authorised share capital stood at Rs 186 crore, divided into 18.60 crore shares of Rs 10 each, while the subscribed and paid-up capital was Rs 112.35 crore divided into 11.23 crore shares. After the split, the authorised capital will remain Rs 186 crore but divided into 186 crore shares of Rs 1 each, with subscribed and paid-up capital of Rs 112.35 crore divided into 112.35 crore shares. The record date will be declared after shareholder approval through a postal ballot.
Bonus Issue in 1:10 Ratio
The company also approved a bonus issue in the ratio of 1:10, providing one bonus share for every ten existing equity shares. This will lead to the issue of approximately 1.12 crore new equity shares valued at Rs 11.23 crore.
Advertisement:
50% OFF on DSIJ Digital Magazine
The bonus shares, fully paid-up with a face value of Rs 10 each, will be financed through capitalisation of the securities premium account, free reserves, and retained earnings. As of June 30, 2025, Welcure Drugs had free reserves of Rs 13.37 crore. Post-bonus, the paid-up share capital will rise from Rs 112.35 crore to Rs 123.59 crore. Bonus share credit or dispatch is expected within two months, subject to shareholder approval.
Increase in Authorised Share Capital
The Board further approved an increase in authorised share capital from Rs 186 crore to Rs 196 crore. This requires an amendment to Clause V (Capital Clause) of the Memorandum of Association. The revised capital will be divided into 19.60 crore equity shares of Rs 10 each.
Incorporated in 1992, Welcure Drugs And Pharmaceuticals Ltd used to manufacture pharmaceuticals products. Company manufactures and markets pharmaceutical formulations in the form of tablets, capsules, dry syrups, antibiotics, sulpha drugs, vitamins, analgesics, antipyretics, corticosteroids, anti-malarial, anti-dysentery, anti-tuberculosis, anti-diabetics, tranquilizers, sedatives and gastrointestinal.
The stock is up by 97 per cent from its 52-week low of Rs 6.40 per share and has given multibagger returns of 630 per cent in 5 years.
Disclaimer: The article is for informational purposes only and not investment advice.